Ketamine induces insomnia‐like symptom of zebrafish at environmentally relevant concentrations by mediating GABAergic synapse
Environmental Toxicology · 2024
DOI: 10.1002/tox.24227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Tingting Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Si…. Hauptthemen laut MEDLINE: Zebrafish, Ketamine, Sleep Initiation and Maintenance Disorders. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Schlaf
Abstract (Originalsprache)
Although the stimulative effects on the normal behaviors of fish posed by ketamine (KET) were well‐studied, the adverse effects on the behavioral functions induced by KET at nighttime were unknown. Here, we used zebrafish larvae as a model exposed to KET (10, 50, 100, and 250 ng/L) at environmental levels for 21 days. The behavioral functions at nighttime, morphological changes during exposure stage, and alterations on the associated genes transcriptional levels of fish were determined. The difficultly initiating sleep was found in the fish exposed to KET, while the sleep duration of the animals was at the normal levels in exposure groups. The significant suppressions of the developmentally relevant genes, including bmp2 , bmp4 , and pth2ra were consistent with the developmental abnormalities of fish found in exposure groups. Moreover, the expression of γ‐aminobutyric acid (GABA) receptor increased and melatonin (MTN) receptor decreased while the levels of GABA and MTN remained unchanged after exposure, by gene expression analysis and molecular docking. In addition, the transcriptional expression of apoptotic genes, including tp53 , aifm1 , and casp6 , was significantly upregulated by KET. After a 7‐day recovery, the insomnia‐like behaviors (shorter sleep duration) were observed in zebrafish from the 250 ng/L‐KET group. Accordingly, the adverse outcome pathway framework of KET was constructed by prognostic assessment of zebrafish larvae. This study suggested that the adverse outcomes of KET on the sleep health of organisms at environmentally relevant concentrations should be concerned.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
- College of Ecology and Environment, Chengdu University of Technology, Chengdu, People's Republic of China.
- West China School of Public Health, Sichuan University, Chengdu, Sichuan, People's Republic of China.
- Division of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
- National Center for Geriatrics Clinical Medicine Research, Department of Geriatrics and Gerontology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
ORCID-Profile: Shuiping Dai
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, T., He, Y., Mao, S., Yang, Y., Xie, H., Zhang, S., & Dai, S. (2024). Ketamine induces insomnia‐like symptom of zebrafish at environmentally relevant concentrations by mediating GABAergic synapse. Environmental Toxicology. https://doi.org/10.1002/tox.24227
Vancouver
Guo T, He Y, Mao S, Yang Y, Xie H, Zhang S, et al. Ketamine induces insomnia‐like symptom of zebrafish at environmentally relevant concentrations by mediating GABAergic synapse. Environmental Toxicology. 2024. doi:10.1002/tox.24227
BibTeX
@article{Guo2024,
author = {Guo, Tingting and He, Yuhang and Mao, Shengqiang and Yang, Ying and Xie, Hongguan and Zhang, Sifan and Dai, Shuiping},
title = {Ketamine induces insomnia‐like symptom of zebrafish at environmentally relevant concentrations by mediating GABAergic synapse},
journal = {Environmental Toxicology},
year = {2024},
doi = {10.1002/tox.24227}
}
EUVIMED